发明名称 Factor VII polypeptides that are modified and uses thereof
摘要 Modified factor VII polypeptides and uses thereof are provided. Such modified FVII polypeptides include Factor VIIa and other forms of Factor VII. Among modified FVII polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
申请公布号 US9476037(B2) 申请公布日期 2016.10.25
申请号 US201313987492 申请日期 2013.07.30
申请人 Catalyst Biosciences, Inc. 发明人 Madison Edwin L.;Thanos Christopher
分类号 C12N9/64;A61K38/36 主分类号 C12N9/64
代理机构 Dentons US LLP 代理人 Dentons US LLP ;Seidman Stephanie
主权项 1. A modified factor VII (FVII) polypeptide, comprising amino acid replacements at positions corresponding to positions 286 and 298 in a FVII polypeptide having the sequence of amino acids set forth in SEQ ID NO:3, wherein: the amino acid replacement at position 286 is Arg (R), and at position 298 is Gln (Q); the modified FVII polypeptide, when in an activated form, exhibits procoagulant activity; and the amino acid sequence of the modified FVII polypeptide has at least 90% sequence identity with a polypeptide having the sequence of amino acids set forth in any of SEQ ID NOs:1-3.
地址 South San Francisco CA US
您可能感兴趣的专利